KRAS and cancer: K-ras mutations, as part of the Ras pathway, likewise decreases RhoB transcription inhibiting the myriad of pathways regulated by RhoB and is linked with worse prognosis in several cancer types [28,33,34,35,36,37,38,39,40,41,42,43,45,46,47,48,49,50,52,80].